glp-1 obesity drug market size 2025 Receptor Agonist Outlook for obesity in 2025:

[4] Patients should be counseled to monitor their blood pressure at home if possible, recording measurements at consistent times and noting any symptoms

GLP-1 receptor agonists stimulate glucose-dependent insulin secretion and suppress appetite, whilst metformin reduces hepatic glucose production and enhances insulin sensitivity

It not only supports weight loss but has additional health rewards too

Prioritizing protein at every meal, using shakes or bars as supplements, and tracking intake carefully prevents the excessive lean mass loss that gives these medications a bad reputation for "making you skinny fat." Ignoring hydration Reduced food intake means reduced water intake from food sources

Tesfaye S, et al

Over-correction Although surgeons typically slightly overfill to account for expected reabsorption, occasionally graft take is higher than expected and the final result is more full than intended